Frovatriptan drug interactions: Difference between revisions
(Created page with "__NOTOC__ {{Frovatriptan}} {{CMG}}; {{AE}} {{SS}} ==Drug Interactions== <div>===Ergot-containing Drugs=== Ergot-containing drugs have been reported to cause prolonged vasosp...") |
|||
| Line 4: | Line 4: | ||
==Drug Interactions== | ==Drug Interactions== | ||
===Ergot-containing Drugs=== | |||
Ergot-containing drugs have been reported to cause prolonged vasospastic reactions. Because these effects may be additive, use of ergotamine-containing or ergot-type medications (like [[dihydroergotamine]] or [[methysergide]]) and FROVA within 24 hours of each other is contraindicated [see Contraindications (4)]. | Ergot-containing drugs have been reported to cause prolonged vasospastic reactions. Because these effects may be additive, use of ergotamine-containing or ergot-type medications (like [[dihydroergotamine]] or [[methysergide]]) and FROVA within 24 hours of each other is contraindicated [see Contraindications (4)]. | ||
| Line 14: | Line 14: | ||
===Selective [[Serotonin]] Reuptake Inhibitors / [[Serotonin]] [[Norepinephrine]] Reuptake Inhibitors and [[Serotonin]] Syndrome=== | ===Selective [[Serotonin]] Reuptake Inhibitors / [[Serotonin]] [[Norepinephrine]] Reuptake Inhibitors and [[Serotonin]] Syndrome=== | ||
Cases of [[Serotonin]] syndrome have been reported during combined use of triptans and [[SSRIs]], [[SNRI]]s, TCAs, and [[MAO]] inhibitors [see Warnings and Precautions (5.7)].<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = FROVA (FROVATRIPTAN SUCCINATE) TABLET, FILM COATED [ENDO PHARMACEUTICALS INC.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c0703630-9ce8-4259-841e-71fd2019fa66 | publisher = | date = | accessdate = 7 February 2014 }}</ref | Cases of [[Serotonin]] syndrome have been reported during combined use of triptans and [[SSRIs]], [[SNRI]]s, TCAs, and [[MAO]] inhibitors [see Warnings and Precautions (5.7)].<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = FROVA (FROVATRIPTAN SUCCINATE) TABLET, FILM COATED [ENDO PHARMACEUTICALS INC.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c0703630-9ce8-4259-841e-71fd2019fa66 | publisher = | date = | accessdate = 7 February 2014 }}</ref> | ||
==References== | ==References== | ||
Revision as of 17:25, 7 February 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sheng Shi, M.D. [2]
Drug Interactions
Ergot-containing Drugs
Ergot-containing drugs have been reported to cause prolonged vasospastic reactions. Because these effects may be additive, use of ergotamine-containing or ergot-type medications (like dihydroergotamine or methysergide) and FROVA within 24 hours of each other is contraindicated [see Contraindications (4)].
HT1B/1D Agonists
Because their vasospastic effects may be additive, co-administration of FROVA and other 5-HT1 agonists (e.g., triptans) within 24 hours of each other is contraindicated [see Contraindications (4)].
Selective Serotonin Reuptake Inhibitors / Serotonin Norepinephrine Reuptake Inhibitors and Serotonin Syndrome
Cases of Serotonin syndrome have been reported during combined use of triptans and SSRIs, SNRIs, TCAs, and MAO inhibitors [see Warnings and Precautions (5.7)].[1]
References
- ↑ "FROVA (FROVATRIPTAN SUCCINATE) TABLET, FILM COATED [ENDO PHARMACEUTICALS INC.]". Retrieved 7 February 2014.